Name
JR SK OÜ
Registry code
14206805
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.02.2017 (8)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86221 - Provision of specialised medical treatment
-48 432 €
31 971 €
45%
910 €
(estimate is approximate)
105 649 €
6
-
No tax arrears
30%
30%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Jaan Reimand
| 100% - 2 500.00 EUR | Board member | - | Founder |
| 2019 02.09.2020 | 2020 10.06.2021 | 2021 13.06.2022 | 2022 01.07.2023 | 2023 26.06.2024 | 2024 19.05.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 28 753 € | 31 567 € | 42 374 € | 42 652 € | 71 680 € | 79 587 € |
| Net profit (loss) for the period | 10 295 € | 15 212 € | 21 336 € | 16 426 € | 31 971 € | 14 206 € |
| Profit Margin | 36% | 48% | 50% | 39% | 45% | 18% |
| Current Assets | 20 939 € | 36 238 € | 57 762 € | 75 194 € | 107 938 € | 40 439 € |
| Fixed Assets | - | - | - | - | - | - |
| Total Assets | 20 939 € | 36 238 € | 57 762 € | 75 194 € | 107 938 € | 40 439 € |
| Current Liabilities | 234 € | 321 € | 509 € | 1 515 € | 2 289 € | 28 584 € |
| Non Current Liabilities | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - |
| Share Capital | - | - | - | - | - | - |
| Equity | 20 705 € | 35 917 € | 57 253 € | 73 679 € | 105 649 € | 11 855 € |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | - | 3 492 € | 3 847 € | 2 |
| 2025 Q3 | - | 3 075 € | 3 400 € | 2 |
| 2025 Q2 | - | 2 696 € | 3 009 € | 2 |
| 2025 Q1 | - | 27 869 € | 1 044 € | 2 |
| 2024 Q4 | - | 1 093 € | 1 219 € | 1 |
| 2024 Q3 | - | 1 106 € | 1 232 € | 1 |
| 2024 Q2 | - | 994 € | 1 111 € | 1 |
| 2024 Q1 | - | 1 079 € | 1 203 € | 1 |
| 2023 Q4 | - | 1 024 € | 1 143 € | 1 |
| 2023 Q3 | - | 854 € | 959 € | 1 |
| 2023 Q2 | - | 775 € | 873 € | 1 |
| 2023 Q1 | - | 791 € | 886 € | 1 |
| 2022 Q4 | - | 208 € | 236 € | 1 |
| 2022 Q3 | - | - | - | 1 |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | - | - | - | - |
